NLRP3 and Alzheimer disease: Our data showed that SH significantly decreased the expressions of NLRP3, ASC, caspase-1, and GSDMD-N in Aβ1-42-induced AD in vitro, suggesting that SH could inhibit the activation of the NLRP3/GSDMD pathway in AD.